HES 130/0.4 (Voluven®) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial
Thomas Standl(Universität Hamburg), H. Hagemann(Hahnemann University Hospital), Adam Reich(Rzeszów University of Technology), C. Galli(Istituti Ospitalieri di Cremona), H. Lochbuehler, G. Dietrich(University of Arkansas for Medical Sciences)
Cited by 64
Related Papers
Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients
|Food and Chemical Toxicology|2007|1.8k
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus
|Acta Dermato Venereologica|2012|579
Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus
|Acta Dermato Venereologica|2012|502